Are Lorazepam-Induced Deficits in Attention Similar to Those Resulting From Aging?

The purpose of this experiment was to compare, in three tasks of attention, the impairment caused by lorazepam (1 and 2.5 mg) administered to young volunteers with the impairment that results from aging. Performance on digit cancellation (DC), digit-symbol substitution (DSS), and Paced Auditory Serial Addition Task (PASAT) was significantly impaired by lorazepam (2.5 mg) and was significantly worse in the middle-aged group (mean ± SEM, aged 58.9 ± 0.8 years) compared with the younger, IQ-matched group (20.7 ± 0.2 years). However, there were interesting differences in the extent of impairments among the three tests. In the DC test, lorazepam (2.5 mg) produced a significantly greater impairment than was seen in either the middle-aged men or middle-aged women. However, in the DSS test, the middle-aged women were significantly more impaired than either the middle-aged men or the young volunteers tested after lorazepam (2.5 mg). In the PASAT, both the lorazepam (2.5 mg) group and the middle-aged women were more impaired than the middle-aged men. These results raise the important possibility of gender differences in age-related decline of attentional processes.

[1]  Y. Kitamura,et al.  Alterations in acetylcholine, NMDA, benzodiazepine receptors and protein kinase C in the brain of the senescence-accelerated mouse: an animal model useful for studies on cognitive enhancers , 1997, Behavioural Brain Research.

[2]  S. Larson,et al.  Midazolam Changes Cerebral Blood Flow in Discrete Brain Regions: An H2‐15O Positron Emission Tomography Study , 1997, Anesthesiology.

[3]  M. I. Al-Dahan,et al.  Age-related levels of GABA/benzodiazepine binding sites in cerebrum of F-344 rats: Effects of exercise , 1995, Neurobiology of Aging.

[4]  S. Mewaldt,et al.  Benzodiazepines and Human Memory: A Review , 1990, Anesthesiology.

[5]  A. Gutiérrez,et al.  Altered expression of γ2L and γ2S GABAA receptor subunits in the aging rat brain , 1996 .

[6]  K. Hanaoka,et al.  The Effects of Age and Gender on the Optimal Premedication Dose of Intramuscular Midazolam , 1998 .

[7]  S. File.  A comparison of the effects of a secondary task and lorazepam on cognitive performance , 1992, Journal of psychopharmacology.

[8]  T. Duka,et al.  β -Carbolines as Tools in Memory Research: Human Data with the β -Carboline ZK 93426 , 1988 .

[9]  T. Marczynski,et al.  GABAergic Deafferentation Hypothesis of Brain Aging and Alzheimer's Disease; Pharmacologic Profile of the Benzodiazepine Antagonist, Flumazenil , 1995, Reviews in the neurosciences.

[10]  T. Salthouse.  The processing-speed theory of adult age differences in cognition. , 1996, Psychological review.

[11]  Thomas E. Nichols,et al.  Anterior cingulate gyrus dysfunction and selective attention deficits in schizophrenia: [15O]H2O PET study during single-trial Stroop task performance. , 1997, The American journal of psychiatry.

[12]  Richard S. J. Frackowiak,et al.  Functional localization of the system for visuospatial attention using positron emission tomography. , 1997, Brain : a journal of neurology.

[13]  R. Knight,et al.  Prefrontal deficits in attention and inhibitory control with aging. , 1997, Cerebral cortex.

[14]  N. Volkow,et al.  Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. , 1998, The American journal of psychiatry.

[15]  N. Volkow,et al.  Enhanced sensitivity to benzodiazepines in active cocaine-abusing subjects: a PET study. , 1998, The American journal of psychiatry.

[16]  A. Bond,et al.  The use of analogue scales in rating subjective feelings , 1974 .

[17]  Holly E. Hancock,et al.  Controlled and automatic forms of memory and attention: process purity and the uniqueness of age-related influences. , 1997, The journals of gerontology. Series B, Psychological sciences and social sciences.

[18]  R. Dolan,et al.  The Neural Correlates of the Noradrenergic Modulation of Human Attention, Arousal and Learning , 1997, The European journal of neuroscience.

[19]  J. Gillin.  The long and the short of sleeping pills. , 1991, The New England journal of medicine.

[20]  L. Jarvik,et al.  Human intelligence: sex differences. , 1975, Acta geneticae medicae et gemellologiae.

[21]  P. Pietrini,et al.  Sex differences in human brain morphometry and metabolism: an in vivo quantitative magnetic resonance imaging and positron emission tomography study on the effect of aging. , 1996, Archives of general psychiatry.

[22]  D. Gronwall,et al.  Delayed recovery of intellectual function after minor head injury. , 1974, Lancet.

[23]  J. Vanakoski,et al.  Lorazepam and diazepam differently impair divided attention , 1995, Pharmacology Biochemistry and Behavior.

[24]  S. File.  Age and anxiety: Increased anxiety, decreased anxiolytic, but enhanced sedative, response to chlordiazepoxide in old rats , 1990 .

[25]  N. Matsokis,et al.  Brain benzodiazepine binding in aged rats , 1998, Neurochemistry International.

[26]  R. Snaith,et al.  The Hospital Anxiety and Depression Scale , 1983 .

[27]  C. Martini,et al.  Age-related changes in peripheral benzodiazepine receptors of human platelets. , 1994, Journal of psychiatry & neuroscience : JPN.

[28]  D. Greenblatt,et al.  Sensitivity to triazolam in the elderly. , 1991, The New England journal of medicine.